Browse > Article

Association between the Human Surfactant Protein-A(SP-A) Gene Locus and Chronic Obstructive Pulmonary Disease in Korean Population  

Na, Joo Ock (Department of Internal Medicine, Soonchunhyang University Collage of Medicine)
Oh, Myung Ho (Department of Pediatrics, Soonchunhyang University Collage of Medicine)
Choi, Jae Sung (Department of Internal Medicine, Soonchunhyang University Collage of Medicine)
Seo, Ki Hyun (Department of Internal Medicine, Soonchunhyang University Collage of Medicine)
Kim, Yong Hoon (Department of Internal Medicine, Soonchunhyang University Collage of Medicine)
Publication Information
Tuberculosis and Respiratory Diseases / v.60, no.6, 2006 , pp. 638-644 More about this Journal
Abstract
Backgrounds: This study investigated whether or not a polymorphism in the gene encoding the surfactant protein A(SP-A) has any bearing on the individual susceptibility to the development of chronic obstructive pulmonary disease(COPD) in a genetically homogenous Korean population. Methods: The genotypes of 19 COPD patients and 20 healthy neonates as controls were tested using a polymerase chain reaction followed by restriction fragment length polymorphism analysis for the SP-A gene. Results: The specific frequencies of the 6A2 and 6A18 alleles of SP-A1 and the 1A2 allele of SP-A2 were much higher in the COPD group than control group (p<0.05). However, the frequencies of the 6A3 and 6A4 alleles of SP-A1 and the 1A0 allele of SP-A2 in the COPD group were significantly lower than the control group. In the COPD group, the frequencies of the +50 locus genotypes GG of SP-A1 and the +9 locus genotypes CC of SP-A2 were 85.0% and 60.6%, respectively, and 19.7% and 24.8% in the control group, respectively. The frequencies of the polymorphic genotypes or alleles showed a statistically significant difference between the COPD group and the control group (P<0.05). Conclusion: A genetic polymorphism in SP-A is associated with the development of COPD in the Korean population.
Keywords
Surfactant; SP-A; SP-A alleles; Genotype of SP-A; COPD; Genetic polymorphism;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 ATS Statement. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease: definitions, epidemiology, pathophysiology, diagnosis, and staging. Am J Respir Crit Care Med 1995;152:S77-121
2 Grese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 1999;13:1455-76   DOI   ScienceOn
3 Guo X, Lin HM, Lin Z, Montano M, Sansores R, Wang G, et al. Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population. Eur Respir J 2001;18:482-90   DOI   ScienceOn
4 Guo X, Lin HM, Lin Z, Montano M, Sansores R, Wang G, et al. Polymorphisms of surfactant protein gene A, B, D, and of SP-B-linked microsatellite markers in COPD of a Mexican population. Chest 2000;117(5 Suppl 1):249S-50S   DOI
5 DiAngelo S, Lin Z, Wang G, Philips S, Ramet M, Luo J, et al. Novel, Non-radioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles. Dis Markers 1999;15:269-81   DOI
6 Kim DS, Kim YS, Jung KS, Chang JH, Lim CM, Lee JH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med 2005;172:842-7   DOI   ScienceOn
7 Bascom R. Differential susceptibility to tobacco smoke: possible mechanism. Pharmacogenetics 1991;1:102-6   DOI   ScienceOn
8 Wirtz H, Habscheid W, Ertl G, Schmidt M, Kochsiek K. Exogenous surfactant application in respiratory failure due to chronic obstructive pulmonary disease. Respiration 1995;62:157-9   DOI   ScienceOn
9 Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: NHLBI/WHO workshop report. No. 2701. Bethesda, National Heart, Lung and Blood Institute. NIH Publication, 2001. p. 1–.100
10 Behera D, Balamugesh T, Venkateswarlu D, Gupta A, Majumdar S. Serum surfactant protein-A levels in chronic bronchitis and its relation to smoking. Indian J Chest Dis Allied Sci 2005;47:13-7
11 Wirtz H, Habscheid W, Ertl G, Schmidt M, Kochsiek K. Exogenous surfactant application in respiratory failure due to chronic obstructive pulmonary disease. Respiration 1995;62:157-9   DOI   ScienceOn
12 Bascom R. Differential susceptability to tobacco smoke: possible mechanisms. Pharmacogenetics 1991;1:102-6   DOI   ScienceOn
13 Fujishima T, Takahashi H, Abe S. Cytokines and surfactant as a factor of onset and progression of COPD. Nippon Rinsho 1999;57:1976-81
14 Kim NC, Yoon HC, Suk JS, Ko JH, Yoo OJ, Lee IK, Oh MH, Bae CW, Allele distribution and freguency of human surfactant protein-Azin Korean neonates, J. Korean Pediatr Soc. 2003;46:340-4
15 Lusuardi M, Capelli A, Carli S, Tacconi MT, Salmona M, Donner CF. Role of surfactant in chronic obstructive pulmonary disease: therapeutic implications. Respiration 1992;59(Suppl):28-32
16 Lee KS, Kim YH, Suk JS, Ko JH, OH MH, Baw CW. Allele distribution and frequency of human surfactant protein-AI in Korean neonates. J. Korean Pediatr Soc 2002;45:1797-502
17 Otto-Verberne CJ, Ten Have-Opbroek AA, Franken C, Hermans J, Dijkman JH. Protective effect of pulmonary surfactant on elastase-induced emphysema in mice. Eur Respir J 1992;5:1223-30
18 Xie JG, Xu YJ, Zhang ZX, Ni W, Chen SX. Surfactant protein A gene polymorphisms in chronic obstructive pulmonary disease. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2005;22:91-3
19 Seifart C, Plagens A, Brodje D, Muller B, von Wichert P, Floros J. Surfactant protein B intron 4 variation in German patients with COPD and acute respiratory failure. Dis Markers 2002;18:129-36   DOI